Exciting news in the realm of stroke prevention! The OPTION Trial highlights the safety and effectiveness of left atrial appendage closure (LAAC) using the Watchman FLX™ device as an alternative to oral anticoagulants in patients undergoing AFib ablation.
This study reinforces the potential of LAAC to reduce stroke risk while addressing bleeding concerns, offering hope for patients seeking advanced care options.
Explore the full details of the OPTION Trial here: https://www.bostonscientific.com/en-US/products/laac-system/option-clinical-trial/option-clinical-trial-for-physicians/the-option-clinical-trial.html
#strokeprevention #LAAC #OPTIONtrial #BostonScientific #WatchmanFLX #DHSHungary #DeliveringHealthcareSolutions
